JVLIX | RMFEX | JVLIX / RMFEX | |
Total Expense Ratio | 0.71 | 0.62 | 115% |
Annual Report Gross Expense Ratio | 0.72 | 0.62 | 116% |
Fund Existence | 28 years | 23 years | - |
Gain YTD | 4.633 | 6.152 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 250 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.5B | 107B | 16% |
Annual Yield % from dividends | 0.98 | 1.58 | 62% |
Returns for 1 year | -2.07 | 9.03 | -23% |
Returns for 3 years | 13.21 | 29.63 | 45% |
Returns for 5 years | 42.58 | 62.32 | 68% |
Returns for 10 years | 29.42 | 76.27 | 39% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
REK | 16.95 | 0.14 | +0.83% |
ProShares Short Real Estate | |||
FIBR | 87.66 | -0.15 | -0.18% |
iShares U.S. Fixed Inc Bal Rsk Sysmc ETF | |||
NEA | 10.82 | -0.08 | -0.71% |
Nuveen AMT-Free Quality Municipal Income Fund | |||
AOK | 38.37 | -0.32 | -0.83% |
iShares Core 30/70 Cnsrv Allc ETF | |||
PBE | 63.94 | -0.80 | -1.24% |
Invesco Biotechnology & Genome ETF |